- Teva, Mylan launch Viagra generics in Europe
- State of the market: Are generic drugs approaching their peak?
- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- Mylan launches generic anti-fungal drug
- CVS Caremark aims to help customers as survey spotlights ACA knowledge gap
PITTSBURGH — The Food and Drug Administration has approved a generic drug for depression and anxiety made by Mylan, the drug maker said Thursday.
Mylan announced the approval of venlafaxine hydrochloride extended-release capsules in the 37.5-mg, 75-mg and 150-mg strengths.
The drug, used to treat major depressive disorder and social anxiety disorder, is a generic version of Effexor XR, made by Wyeth. Mylan is launching the drug under a licensing agreement it made with Wyeth before its purchase by Pfizer.
Velafaxine hydrochloride extended-release capsules had sales of $2.3 billion during the 12 months ended in March, according to IMS Health.